Orthopaedic Innovations L L C Clive, IA - 50325

Orthopaedic Innovations L L C is categorized under Orthopedic Doctors and Physicians in Clive, IA and active since 2008.

Orthopaedic Innovations L L C was established in 2008, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Orthopedic Doctors and Physicians business, which does work in the B2C market, and is classified as a Orthopedic Doctors and Physicians, under code number 621111 by the NAICS.

If you are seeking more information, feel free to contact David L Wetsch at the company’s single location by writing to 1556 Nw 125th St, Clive, Iowa IA 50325 or by phoning (515) 224-7505. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Orthopaedic Innovations L L C
Contact Person: David L Wetsch
Address: 1556 Nw 125th St, Clive, Iowa 50325
Phone Number: (515) 224-7505
Annual Revenue (USD): $100.000 to $499.999
Founded: 2008
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Orthopedic Doctors and Physicians
SIC Code: 8011
NAICS Code: 621111
Share This Business:

Orthopaedic Innovations L L C was started in 2008 to provide professional Orthopedic Doctors and Physicians under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.

Feel free to contact David L Wetsch for inquiries that concern Orthopaedic Innovations L L C by calling the company number (515) 224-7505, as your correspondence is most welcome. Additionally, the physical location of the single location of Orthopaedic Innovations L L C can be found at the coordinates 41.605088,-93.791443 as well as the street address 1556 Nw 125th St in Clive, Iowa 50325.

For its online presence, you may visit Orthopaedic Innovations L L C’s website at and engage with its social media outlets through on Twitter and on Facebook.